Amgen
Amgen Inc.
1 Amgen Center Drive
Thousand Oaks,
CA 91320-1799
Phone: (805) 447-1000Website: https://www.amgen.com/Careers: careers.amgen.comPatient Assistance Program: www.amgen.com/responsibility...
Latest news
- FDA Approves Lumakras (sotorasib) in Combination with Vectibix (panitumumab) for Chemorefractory KRAS G12C-Mutated Metastatic Colorectal Cancer
17 January 2025 - FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea
23 August 2024 - FDA Approves Blincyto (blinatumomab) in CD19-Positive Philadelphia Chromosome-Negative B-ALL in the Consolidation Phase
14 June 2024 - FDA Approves Bkemv (eculizumab-aeeb), an Interchangeable Biosimilar to Soliris
28 May 2024 - FDA Grants Accelerated Approval for Imdelltra (tarlatamab-dlle) for the Treatment of Extensive-Stage Small Cell Lung Cancer
16 May 2024 - Amgen Provides Regulatory Update on Status of Lumakras (sotorasib)
26 December 2023 - FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
13 December 2023 - FDA Approves Wezlana (ustekinumab-auub), an Interchangeable Biosimilar to Stelara
31 October 2023 - Amgen Presents New Tarlatamab Data In Small Cell Lung Cancer
20 October 2023 - FDA Grants Full Approval for Blincyto (blinatumomab) to Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
21 June 2023
Drugs Associated with Amgen Inc.
Amgen Inc. manufactures, markets and/or distributes more than 38 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Actimmune
Generic name: interferon gamma-1b Drug class: interferons |
||
|
Aimovig
Generic name: erenumab Drug class: CGRP inhibitors |
579 reviews | 5.2 / 10 |
|
Amjevita
Generic name: adalimumab Drug class: antirheumatics, TNF alfa inhibitors |
8 reviews | 7.4 / 10 |
|
Aranesp
Generic name: darbepoetin alfa Drug class: recombinant human erythropoietins |
4 reviews | 9.0 / 10 |
|
Avsola
Generic name: infliximab Drug class: TNF alfa inhibitors |
9 reviews | 6.6 / 10 |
|
Bkemv
Generic name: eculizumab Drug class: selective immunosuppressants |
||
|
Blincyto
Generic name: blinatumomab Drug class: bispecific T-cell engagers (BiTE) |
1 review | 10 / 10 |
|
Buphenyl
Generic name: sodium phenylbutyrate Drug class: urea cycle disorder agents |
||
|
Corlanor
Generic name: ivabradine Drug class: miscellaneous cardiovascular agents |
6 reviews | 8.2 / 10 |
|
Enbrel
Generic name: etanercept Drug class: antirheumatics, TNF alfa inhibitors |
278 reviews | 7.8 / 10 |
|
Epogen
Generic name: epoetin alfa Drug class: recombinant human erythropoietins |
2 reviews | 8.5 / 10 |
|
Evenity
Generic name: romosozumab Drug class: miscellaneous bone resorption inhibitors |
57 reviews | 6.2 / 10 |
|
Imdelltra
Generic name: tarlatamab Drug class: bispecific T-cell engagers (BiTE) |
||
|
Imlygic
Generic name: talimogene laherparepvec Drug class: miscellaneous antineoplastics |
||
|
Kanjinti
Generic name: trastuzumab Drug class: HER2 inhibitors |
||
|
Krystexxa
Generic name: peglase Drug class: antihyperuricemic agents |
11 reviews | 8.8 / 10 |
|
Kyprolis
Generic name: carfilzomib Drug class: proteasome inhibitors |
4 reviews | 5.8 / 10 |
|
Lumakras
Generic name: sotorasib Drug class: miscellaneous antineoplastics |
1 review | 10 / 10 |
|
Mvasi
Generic name: bevacizumab Drug class: VEGF/VEGFR inhibitors |
||
|
Neulasta
Generic name: pegfilgrastim Drug class: colony stimulating factors |
63 reviews | 5.4 / 10 |
|
Neupogen
Generic name: filgrastim Drug class: colony stimulating factors |
3 reviews | 10 / 10 |
|
Nplate
Generic name: romiplostim Drug class: platelet-stimulating agents |
10 reviews | 7.6 / 10 |
|
Otezla
Generic name: apremilast Drug class: antirheumatics |
405 reviews | 5.2 / 10 |
|
Parsabiv
Generic name: etelcalcetide Drug class: calcimimetics |
||
|
Pavblu
Generic name: aflibercept Drug class: anti-angiogenic ophthalmic agents |
||
|
Procysbi
Generic name: cysteamine Drug class: miscellaneous uncategorized agents |
||
|
Prolia
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
328 reviews | 2.8 / 10 |
|
Ravicti
Generic name: glycerol phenylbutyrate Drug class: urea cycle disorder agents |
||
|
Repatha
Generic name: evolocumab Drug class: PCSK9 inhibitors |
586 reviews | 5.3 / 10 |
|
Riabni
Generic name: rituximab Drug class: CD20 monoclonal antibodies |
||
|
Sensipar
Generic name: cinacalcet Drug class: calcimimetics |
9 reviews | 5.7 / 10 |
|
Tavneos
Generic name: avacopan Drug class: selective immunosuppressants |
1 review | 2.0 / 10 |
|
Tepezza
Generic name: teprotumumab Drug class: growth hormone receptor blockers |
5 reviews | 8.4 / 10 |
|
Tezspire
Generic name: tezepelumab Drug class: selective immunosuppressants |
29 reviews | 8.9 / 10 |
|
Uplizna
Generic name: inebilizumab Drug class: selective immunosuppressants |
||
|
Vectibix
Generic name: panitumumab Drug class: EGFR inhibitors |
3 reviews | 6.3 / 10 |
|
Wezlana
Generic name: ustekinumab Drug class: interleukin inhibitors |
||
|
Xgeva
Generic name: denosumab Drug class: miscellaneous bone resorption inhibitors |
8 reviews | 6.6 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||